Global Swab and Viral Transport Medium Market Size

Swab & Viral Transport Medium Market Analysis

The Global Swab and Viral Transport Medium Market size is estimated at USD 759.78 million in 2024, and is expected to reach USD 914.21 million by 2029, growing at a CAGR of 3.77% during the forecast period (2024-2029).

The COVID-19 outbreak is expected to have a significant impact on the swab and viral transport tedium market due to the increasing demand for the diagnosis of the infections among patients .The swab and viral transport medium is expected to grow due to the intensified experiments for the COVID-19 in the research organizations and labs for developing vaccinations. The increasing research and development activities to produce COVID-19 vaccination are expected to propel the growth of the market during the pandemic period.

The increasing cases of COVID-19 among people across the globe are expected to propel the growth of the market. Owing to the need for developing vaccination and early diagnosis to treat the infection is expected to boost the growth of the market. According to World Health Organization (WHO), there were approximately 404 million COVID-19 cases recorded in the world till February 2022. Additionally, the report states that 5.7 million deaths were recorded across the world in 2022. The COVID-19 pandemic has led to an unexpected negative impact on the growth of almost all industrial sectors due to the sudden imposition of lockdown. Several economies across the world faced unprecedented losses due to the lack of labor and disruptions in the supply chains. The need for diagnosis of this COVID-19 infection in order to control the disease rate for the economies to rise again led to the demand for the swab and viral transport medium across the world. This increase in the incidence of many other infectious diseases across the globe led to the increase in demand for swabs and transport mediums resulting in the growth of the market. Moreover, a Surge in the number of new viruses emerging that can cause various diseases in humans is an additional factor contributing to the growth of the swab and Viral transport medium market. According to the article published in Nature, in 2021, Now, as pandemic restrictions ease, some respiratory viruses are returning in unexpected ways. Infections with Respiratory Syncytial Virus (RSV) started to rise in April 2021, which is also responsible for 5% of deaths in children under 5 years worldwide. Hence the increasing incidence of other infectious diseases is expected to drive the growth of the swab and viral transport medium market owing to the rising demand for specimen collection kits and diagnoses.